Author： Ulven Trond Kostenis Evi
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.20, Iss.11, 2010-11, pp. : 1505-1530
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Novel CRTH2 receptor antagonists
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 1, 2005-01 ,pp. :
Access to resources
Recommend
Indole-based CRTH2 antagonists
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 12, 2005-12 ,pp. :
By Prat Maria Gavaldà Amadeu Fonquerna Silvia Miralpeix Montserrat
Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 10, 2011-10 ,pp. :
The use of indole-3-acetic acids as CRTH2 receptor antagonists
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. :